Trademark: 97272570
Word
MARINA-OLE
Status Date
Tuesday, May 7, 2024
Filing Date
Thursday, February 17, 2022
Published for Opposition
Tuesday, June 28, 2022
5 oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
42 providing medical and scientific research information in the fields of pharmaceuticals and biotechnology
Feb 21, 2022
New Application Entered
May 11, 2022
Correspondence Received In Law Office
Feb 23, 2022
New Application Office Supplied Data Entered
Apr 21, 2022
Assigned To Examiner
Apr 22, 2022
Non-Final Action Written
Apr 22, 2022
Non-Final Action E-Mailed
Apr 22, 2022
Notification Of Non-Final Action E-Mailed
May 11, 2022
Teas Response To Office Action Received
May 11, 2022
Teas/Email Correspondence Entered
May 19, 2022
Approved For Pub - Principal Register
Jun 8, 2022
Notification Of Notice Of Publication E-Mailed
Jun 28, 2022
Published For Opposition
Jun 28, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 23, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 4, 2023
Sou Extension 2 Filed
Feb 13, 2023
Sou Teas Extension Received
Feb 13, 2023
Sou Extension 1 Filed
Feb 13, 2023
Sou Extension 1 Granted
Feb 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 4, 2023
Sou Teas Extension Received
Aug 4, 2023
Sou Extension 2 Granted
Aug 20, 2023
Case Assigned To Intent To Use Paralegal
Aug 20, 2023
Statement Of Use Processing Complete
Sep 21, 2023
Su - Non-Final Action - Written
Aug 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 10, 2023
Teas Statement Of Use Received
Aug 10, 2023
Use Amendment Filed
Sep 21, 2023
Non-Final Action E-Mailed
Sep 21, 2023
Notification Of Non-Final Action E-Mailed
Dec 4, 2023
Teas Response To Office Action Received
Apr 23, 2024
Assigned To Lie
Apr 23, 2024
Teas/Email Correspondence Entered
Apr 23, 2024
Correspondence Received In Law Office
May 7, 2024
Allowed Principal Register - Sou Accepted
May 7, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
